Marshall & Sullivan’s GE HealthCare GEHC Stock Holding History

Marshall & Sullivan’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-178	Closed	-$13.2K	–	60
2025 Q2	$13.2K	Buy	+178	New	+$12.4K	0.01%	93

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall & Sullivan's GEHC Position: Q3 2025 in Review

Marshall & Sullivan sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 178 shares — an estimated $13.2K sold.

Marshall & Sullivan first reported a position in GEHC in Q2 2025 and held it in 1 quarter. The position peaked at $13.2K in Q2 2025. 1,278 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

Marshall & Sullivan reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
Marshall & Sullivan sold 178 GE HealthCare shares in Q3 2025, an estimated $13.2K.
Marshall & Sullivan first reported a position in GE HealthCare in Q2 2025 and held it in 1 quarter.
Marshall & Sullivan's GE HealthCare position peaked at $13.2K in Q2 2025.
1,278 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Marshall & Sullivan's 13F filing for Q3 2025, filed 15 Oct 2025.